- EMEA Innovative Medicine
- About us
- Our responsibilities
- Sustainability
- Placing the life science sector at the core of the EU Competitiveness Compass
Placing the life science sector at the core of the EU Competitiveness Compass

Our recommendations for a vibrant European life science sector
01 Strengthen the competitiveness of the EU single market, while recognizing the specificities on national healthcare systems.
Our key recommendation: Create a well-functioning life science market within the EU single market framework, support investments in EU’s healthcare systems, and implement coordinated and proportionate EU-level policy action to tackle shortages and enhance availability of medicines across the EU.
02 Enable innovation through world-class, agile regulation and a robust intellectual property (IP) framework tailored to the specificities of the EU life science sector and the digital age.
Our key recommendation: Perform regular impact assessments, competitiveness checks, and retrospective assessments of how administrative processes impact the life science sector with a goal to reduce unnecessary red tape by at least 50% by 2029, while championing a robust IP framework to provide legal certainty and encourage innovation and investment.
Future-proofing the EU’s medicine regulations
Nicky Willson, Senior Director Regulatory Policy Leader EMEA and Anouk De Vroey Head of Government Affairs & Policy EMEA discuss what is needed to Future-proof the EU’s medicine regulations


To learn more about the importance of IP to medical innovation watch
03 Support research and investment in the EU life science ecosystem.
Our key recommendation: Include the EU life science sector as a key pillar in any future EU funding program to support the whole ecosystem – from start-ups to established life-science companies.
04 Develop an environmental sustainability framework that strengthens European competitiveness and recognizes the complexities of the life science sector.
Our key recommendation: Develop an environmental sustainability framework that drives positive change by encouraging innovation, strengthens European competitiveness, and takes a holistic approach to developing more environmentally sustainable healthcare systems that prioritise patient safety and improved patient outcomes.
05 Bolster the number of highly qualified workers in the EU life science sector.
Our key recommendation: Incorporate the life science sector as a critical component in the European skills agenda, double the number of STEM graduates a year, and attract and retain an international and highly skilled workforce.
06 Champion open trade policies that ensure free flow of goods and services.
Our key recommendation: Recognise the value of global and diversified networks for R&D, manufacturing and supply of medicines and medical devices, against the worrying trend of reshoring and localisation.
Leveraging supply chains to avoid medicine shortages


FOOTNOTES
1 EC; European Neighbourhood Policy and Enlargement Negotiations (DG NEAR); 2024;
https://cyprus.representation.ec.europa.eu/news/speech-president-von-der-leyen-european-parliament-plenary-new-college-commissioners-and-its-2024-11-27_en Last accessed April ‘25
2 EC; Europe seeks to tackle ‘brain drain’ of young people from hard-hit regions; 2022;
https://ec.europa.eu/regional_policy/whats-new/panorama/2022/10/10-05-2022-europe-seeks-to-tackle-brain-drain-of-young-people-from-hard-hit-regions_en Last accessed April ‘25
3 Science Europe; Talent Retention: How can Europe tackle; 2022
https://scienceeurope.org/events/talent-retention-how-can-europe-tackle-the-challenges-of-brain-drain-and-capacity-building-in-eu13-countries/ Last accessed April ‘25
4 EFPIA; 2022;
https://www.efpia.eu/media/676753/cra-efpia-investment-location-final-report.pdf Last accessed April ‘25
5 EFPIA;
https://efpia.eu/media/2rxdkn43/the-pharmaceutical-industry-in-figures-2024.pdf Last accessed April ‘25
6 MedTech Europe; Facts & Figures 2024;
https://www.medtecheurope.org/wp-content/uploads/2024/07/medtech-europes-facts-figures-2024.pdf Last accessed April ‘25
7 Attracting life science investments in Europe report; 2023
https://www.europabio.org/wp-content/uploads/2023/10/Life-Science-Attractiveness-2023-October-22-Final.pdf Last accessed April ‘25
8 EC; 2050 long-term strategy;2024;
https://climate.ec.europa.eu/eu-action/climate-strategies-targets/2050-long-term-strategy_en Last accessed April ‘25
9 Eurostat Statistics Explained; 2023;
https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Tertiary_education_statistics#Graduates Last accessed April ‘25
* Please note that there may be instances of double-counting between the data for the pharmaceuticaland medical technology sectors.